Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› A Coruña
Clinical trial register · Spain

Clinical Trials in A Coruña, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 15 Alicante 14 Badalona 13 Bilbao 10 A Coruña 10
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona15 Alicante14 Badalona13 Bilbao10 A Coruña10
All 29 locations
Target enrolment
to

Trials with a site in A Coruña

10 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Fundación GECP
Phase 2
97
Alicante, Badalona, Barcelona, Bilbao, Jerez de la Frontera, Girona, Granada, A Coruña
2025-07-08
Recruiting
Fundación GECP
Phase 3
129
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Jerez de la Frontera, A Coruña
2025-02-04
Recruiting
Fundación GECP
Observational
50
Ferrol, Alicante, Badalona, Barcelona, Bilbao, Ciudad Real, Girona, A Coruña
2024-10-03
Active, closed
Fundación GECP
Phase 2
46
Alicante, Badalona, Barcelona, Bilbao, Girona, A Coruña, Lugo, Madrid
2022-11-07
Active, closed
Fundación GECP
Observational
100
A Coruña, Alicante, Badalona, Barcelona, Bilbao, Córdoba, Girona, Pamplona
2022-06-17
Recruiting
Fundación GECP
Phase 2
19
Alicante, Badalona, Barcelona, Bilbao, Girona, Granada, Jaén, A Coruña
2022-03-21
Recruiting
Pathological Response After Neoadjuvant Treatment on NSCLC
NCT05167487Stage IIIA Non-small Cell Lung Cancer
Fundación GECP
Observational
150
A Coruña, Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Majadahonda
2021-12-13
Active, closed
Fundación GECP
Phase 2
71
Badalona, Barcelona, L'Hospitalet de Llobregat, Castellon, Las Palmas de Gran Canaria, Jaén, A Coruña, León
2021-11-18
Active, closed
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
NCT04223596Lung Cancer, NSCLC, NSCLC Stage IIIB, NSCLC Stage IV
Fundación GECP
Phase 2
33
A Coruña, Alicante, Málaga, Palma de Mallorca, Badalona, L'Hospitalet de Llobregat, Barcelona, Las Palmas de Gran Canaria
2020-05-04
Active, closed
NADIM II: Neo-Adjuvant Immunotherapy
NCT03838159Non Small Cell Lung Cancer
Fundación GECP
Phase 2
90
Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Córdoba, Girona, Las Palmas de Gran Canaria, A Coruña
2019-05-15
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/a-coru-a

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in A Coruña that also match the filters currently applied.

How many clinical trials are recruiting in A Coruña?

5 of the 10 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (A Coruña), 10 studies
PhaseStudiesRecruitingShare
Phase 26260%
Observational3230%
Phase 31110%

Most active sponsors

Lead sponsors with the most studies (A Coruña)
Lead sponsorStudiesRecruiting
Fundación GECP105
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.